![]() |
|
|
1 Research Division, Cleveland Clinic Foundation, Cleveland, Ohio
A study has been made of the metabolism of C14-1-hydrazinophthalazine in rats and rabbits.
The activity of various tissues following administration of C14-1-hydrazinophthalazine has been estimated. Eighteen per cent of the dose was circulating in the blood 8 hours after intraperitoneal administration.
Excretion of metabolites of 1-hydrazinophthalazine was rapid, 75% of the radioactivity appearing in the urine in 24 hours.
The following metabolites were identified: 1-hydrazinophthalazine-O-glucuronide, N-acetyl-1-hydrazinophthalazine, unchanged 1-hydrazinophthalazine and its pyruvic hydrazone.
Quantitative estimation of these metabolites by scanning radioactive chromatograms and by isotope dilution showed that 1-hydrazinophthalazine-O-glucuronide (40-50%), 1-hydrazinophthalazine (15%), N-acetyl-1-hydrazinophthalazine (25-30%), hydroxy - 1 - hydrazinophthalazine (<5%), and hydrazinophthalazine pyruvic acid hydrazone (<5%) accounted for all the activity in urine.
1-Hydrazinophthalazine pyruvic hydrazone and N-acetyl-1-hydrazinophthalazine were less toxic than 1-hydrazinophthalazine.
1-Hydrazinophthalazine was found to be unstable at alkaline pH.
Submitted on July 23, 1963